EU okays Roche's new anaemia drug Mircera

(Reuters) - ZURICH, July 26 - Swiss-based pharma firm Roche Holding AG said on Thursday the European Commission had approved its drug Mircera to treat anaemia associated with chronic kidney disease.



The potential blockbuster drug belongs to a class of medicines known as erythropoiesis-stimulating agents. They are used to boost red blood cells in anaemia patients to help avoid the need for blood transfusions.


Read more at Reuters.com Market News

Europe approves once-daily Cialis for impotence

(Reuters) - The drug's maker, Eli Lilly and Co. , said on Monday that the green light from the European Commission meant Cialis was the first erectile dysfunction medicine cleared for continuous use.



Until now, drugs such as Cialis and Pfizer Inc.'s rival product, Viagra, have been taken as needed.


Read more at Reuters.com Government Filings News

EU letter paves way for T.Italia-Telefonica deal

(Reuters) - By Robert Hetz and David Lawsky



MADRID/BRUSSELS, June 13 - The European Commission has cleared the way for investors including Telefonica to buy control of Telecom Italia by telling them Brussels has no authority in the matter, a letter showed.


Read more at Reuters.com Government Filings News

Sanofi's Plavix wins EU backing for stent patients

(Reuters) - Recommendations for marketing approval by the agency's
expert panel are normally endorsed by the European Commission
within a couple of months.




Read more at Reuters.com Government Filings News